Neurocrine Biosciences 8-K Report: Key Updates from December 20, 2024
Based on the provided excerpt from the financial report, here are the key insights extracted:
- Company Information:
- Name: Neurocrine Biosciences, Inc.
- State of Incorporation: Delaware (DE)
- CIK Number: 0000914475
- Address: 6027 Edgewood Bend Court, San Diego, CA 92130
- Phone Number: 858-617-7600
- Filing Details:
- Form Type: 8-K (a report of unscheduled material events or corporate changes)
- Filing Date: December 20, 2024
- Stock Information:
- Stock Ticker Symbol: NBIX
- Exchange: NASDAQ
- Common Stock Par Value: $0.001
- Reporting Period:
- Start Date: December 20, 2024
- End Date: December 20, 2024
- Regulatory Compliance:
- The filing is compliant with SEC regulations, as indicated by the use of XBRL (eXtensible Business Reporting Language) for standardized reporting.
Insights:
- Nature of Filing: As an 8-K filing, this document likely contains critical information regarding a significant event affecting the company, which could be related to financial performance, management changes, or other pivotal corporate actions.
- Timeliness: The report is filed on the same day as the reporting period end, suggesting that it may include immediate and relevant updates concerning the company’s operations or financial status.
This summary provides a concise overview of the essential details from the financial report section you provided.